Stempeutics
India's first off-the-shelf cell therapy treatment for knee osteoarthritis
One injection will cost Rs 1.25 lakh with effects lasting for two years or more
 "India's first off-the-shelf cell therapy treatment for knee osteoarthritis")
Updated On : 19 Sep 2022 | 6:10 AM IST
Stempeutics gets DCGI nod for Phase 3 trial to treat Covid patients
Stempeutics said it has received DCGI clearance to conduct Phase 3 clinical trial on its product for treating COVID-19 patients suffering from acute respiratory distress syndrome (ARDS).
 "Stempeutics gets DCGI nod for Phase 3 trial to treat Covid patients")
Updated On : 18 Jan 2022 | 3:07 PM IST
Cipla partner Stempeutics gets DCGI nod for stem cell-based product
The company's goal is to globalise its product, Stempeucel, for Buerger's Disease, the company's CEO said
 "Cipla partner Stempeutics gets DCGI nod for stem cell-based product")
Updated On : 30 May 2016 | 2:32 PM IST
